Navigation Links
Novan Awarded $7.8 Million Contract by BARDA to Develop a Medical Countermeasure for Thermal Burns
Date:8/26/2013

DURHAM, N.C., Aug. 26, 2013 /PRNewswire/ -- Novan Therapeutics announced today that the U.S. Department of Health and Human Services has entered into a contract with Novan to advance the development of a nitric oxide-based therapy as a topical treatment for thermal burns.  The Biomedical Advanced Research and Development Authority (BARDA), an agency within the Office of the Assistant Secretary for Preparedness and Response, awarded this contract.  It is widely believed a mass casualty event caused by natural or intentional threats to public health could result in tens of thousands of burn patients which would overwhelm the burn care infrastructure presently available in hospitals across the United States. 

(Logo: http://photos.prnewswire.com/prnh/20130228/NE68367LOGO )

Under the terms of the contract, BARDA will provide funding of $7.8 million over two years.  The contract will support the pharmaceutical development of the Nitric Oxide Advanced Healing (NOAH) technology including formulation work, nonclinical toxicology, and proof of concept studies in models of deep partial thickness and full thickness thermal injuries.  This project is designed to enable the future clinical investigation of the medical countermeasure.

"We are honored that BARDA selected our team to develop a nitric oxide therapy for thermal burns," said Nathan Stasko, president of Novan.  Nitric oxide, a molecule produced by the human body, has been demonstrated throughout peer-reviewed literature to speed the migration of epidermal cells, stimulate new blood vessel growth, modulate inflammation, and re-model the wound bed.  Dr. Stasko continued, "The link between nitric oxide and the body's ability to heal is well established.  The challenge is to create stable nitric oxide drugs that 'perform on com
'/>"/>

SOURCE Novan Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novan Announces Promising Results of SB204 Clinical Study
2. Novans SB204 Could Be First Topical Sebum Inhibitor
3. Fountain Valley Regional Medical Center Becomes Orange Countys First Hospital Awarded Advanced Certification In Inpatient Diabetes Care
4. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
5. Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
6. All Time Medical awarded a Google Trusted Store badge.
7. Dynamic Healthcare Services Awarded Two Oxygen Equipment Competitive Bidding Contracts
8. Instrumentation Laboratory Awarded Premier Healthcare Alliance Contract For Hemostasis Product Line
9. Great Lakes NeuroTechnologies Awarded Patent For Technology To Treat Parkinsons Disease With Brain Stimulation During Sleep
10. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
11. Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015   Aratana Therapeutics, ... therapeutics company focused on the licensing, development and commercialization ... that it will present at the Barclays Global ... at the Loews Miami Beach Hotel in ... St. Peter , M.D., President and Chief Executive Officer ...
(Date:3/4/2015)... --Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... the 27th Annual ROTH Conference on March 10, 2015 ... California . To learn more about the ROTH ... live webcast of the presentation will be available on ...
(Date:3/4/2015)... 4, 2015  Heska Corporation (Nasdaq: HSKA ... to Join Its Fourth Quarter and Year End 2014 ... @ 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: www.heska.com ... Earnings Call link on the front page of this ... the web at the address above.  Alternatively, you may ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2Aethlon Medical to Present at the 27th Annual ROTH Conference 2Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... developing breakthrough treatments for human disease, today updated its ... three months ended March 31, 2011.   ... progress.  Results from a mechanistic study of a tablet ...
... Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today ... the U.S. Food and Drug Administration (the "FDA") after carefully ... the reviews of the New Drug Application (the "NDA") for ... March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting ...
Cached Medicine Technology:Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 2Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 3Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 4Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 5Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results 6Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 2Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 3Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 4Cell Therapeutics to Re-submit Pixantrone NDA in Consideration for Accelerated Approval in Accordance with Guidance from FDA's Office of New Drugs 5
(Date:3/4/2015)... Ultraman Florida is a grueling extreme athletic ... bike, and 52.4 mile run. Christian Isakson finished in ... "This race was awesome and tough," Isakson said. "I ... for supporting me through every part of this brutal ... of 40 select participants invited from across the United ...
(Date:3/4/2015)... March 04, 2015 TROY Healthcare Solutions ... which provides the ultimate level of security for prescriptions, ... Hilton Houston Plaza Medical Center located at 6633 Travis ... Beginning at 7 AM, TROY Healthcare Solutions will host ... Solutions will offer brief presentations each hour to introduce ...
(Date:3/4/2015)... Smokers across America are the target ... Love Smokers' from Aqua-Tine, the new brand that helps ... important to establish a clear point of view for ... 'We Love Smokers' elevates the Aqua-Tine brand, gives it ... a bold tone of voice that is also genuinely ...
(Date:3/4/2015)... 04, 2015 Starting February 2015, Dr. ... PRK procedures at their new location in Surrey. , ... King and Dr. Gabriel Chu also provide comprehensive ophthalmology ... is named Fraser Valley Cataract and Laser (FVCL). This ... the College of Physicians and Surgeons of British Columbia. ...
(Date:3/4/2015)... " Optrix by Body Glove ” was ... Report, which takes a look at the latest and ... Steinberg, a special reporter for NewsWatch and a technology ... how they have an ultra-rugged, waterproof case with an ... major player at the Consumer Electronics Show in Las ...
Breaking Medicine News(10 mins):Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:King LASIK relocates to Surrey, British Columbia 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2
... Minn. -- The Medical Publishing Insights and Practices ... journal editors to characterize the persistent and perceived ... identify potential approaches to resolve it. This unique ... Ten Recommendations for Closing the Credibility Gap in ...
... By Randy Dotinga HealthDay Reporter , MONDAY, May ... front of the TV have poorer diets overall, a new study ... that TV watching has anything to do with what kids eat, ... more important than time spent with "American Idol" or "SpongeBob SquarePants." ...
... -- Giving earplugs to patients in the intensive care unit ... onset of delirium, according to a new study. It ... delirium in ICU patients, and research has shown that ICU ... in the ICU from equipment and people coming and going. ...
... hard to diagnose as well as treat, but researchers at ... discovered a way of confirming the disorder using stool samples. ... with pain and discomfort in the abdomen together with changes ... to be linked to dysfunction of the stomach and intestines, ...
... risk of prostate cancer can be beneficial in reducing ... states an article published in CMAJ ( ... Preventive Services Task Force, which last issued prostate screening ... prostate-specific antigen (PSA) screening for men of all ages. ...
... Professor Keon Jae Lee ( http://fand.kaist.ac.kr/ ) from ... has developed new forms of low cost, large-area ... Piezoelectric effects-based nanogenerator technology that converts existing sources ... energy from the nature of wind and waves, ...
Cached Medicine News:Health News:Journals and pharma collaborate on new recommendations 2Health News:Lots of TV May Harm Kids' Diet 2Health News:Lots of TV May Harm Kids' Diet 3Health News:Using Earplugs Eases ICU Patients' Confusion: Study 2Health News:PSA screening to detect prostate cancer can be beneficial to younger and at-risk men 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 12 mm....
Medicine Products: